Sarcosine → HCID 46941016, compound
Reaction equation
[C:1]([BH3-])#[N:2].[Na+].[CH3:5][O:6][CH2:7][C:8]1[CH:13]=[C:12]([C:14]2[O:18][N:17]=[C:16]([C:19]3[CH:26]=[CH:25][C:22]([CH:23]=O)=[C:21]([CH3:27])[CH:20]=3)[N:15]=2)[CH:11]=[CH:10][C:9]=1[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=1[CH3:34].CN[CH2:37][C:38]([OH:40])=[O:39].C(Cl)Cl>CO.C(O)(=O)C>[CH3:5][O:6][CH2:7][C:8]1[CH:13]=[C:12]([C:14]2[O:18][N:17]=[C:16]([C:19]3[CH:26]=[CH:25][C:22]([CH2:23][N:2]([CH3:1])[CH2:37][C:38]([OH:40])=[O:39])=[C:21]([CH3:27])[CH:20]=3)[N:15]=2)[CH:11]=[CH:10][C:9]=1[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=1[CH3:34]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
Sodium cyanoborohydride (35 mg, 0.55 mmol) was added into a solution of 4-(5-(2-(methoxymethyl)-2′-methylbiphenyl-4-yl)-1,2,4-oxadiazol-3-yl)-2-methylbenzaldehyde (194 mg, 0.49 mmol) and 2-(methylamino)acetic acid (86 mg, 0.97 mmol) in a mixture of methanol (3 mL), DCM (3 mL) and acetic acid (75 μl). The mixture was stirred at room temperature overnight and the solvent was then removed in vacuo. The residue was purified by preparative HPLC to give the title compound as a white solid. 1H NMR (DMSO-d6, 400 MHz) δ 8.47-8.31 (1H, m), 8.15-8.09 (1H, m), 8.06-7.99 (2H, m), 7.69 (1H, d, J=7.9 Hz), 7.33-7.20 (4H, m), 7.11 (1H, d, J=7.4 Hz), 4.33 (2H, s), 4.21 (2H, m), 3.67 (2H, s), 3.30 (3H, s), 2.78 (3H, s), 2.54 (3H, s), 2.07 (3H, s). LC/MS (Method A): 472 (M+H)+. HPLC (Method F) Rt 3.19 min (Purity: 98.5%).
Workup
- customthe solvent was then removed in vacuo
- customThe residue was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-00b2d4c676804924afa21b02fa6b13ef
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08815919B2
Reaction notes
Loading…